Risk of Hyperkalemia due to the Administration of Angiotensin Ⅱ Type 1 Receptor Blocker and Calcium Channel Blocker： Retrospective Cohort Study Based on Japanese Medical Information Database.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.